IGC PHARMA, INC.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
Asset Breakdown FY2016
Total Assets: $18.9M
Liabilities Breakdown FY2016
Total Liabilities: $4.9M
Asset Breakdown
Total Assets: $18.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.5M | 7.9% |
| Accounts Receivable | $962.7K | 5.1% |
| Inventory | $162.1K | 0.9% |
| Property, Plant & Equipment | $7.1M | 37.5% |
| Goodwill | $1.2M | 6.3% |
| Intangible Assets | $113.3K | 0.6% |
| Other Assets | $7.9M | 41.8% |
Liabilities Breakdown
Total Liabilities: $4.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $330.6K | 6.7% |
| Long-Term Debt | $801.5K | 16.3% |
| Other Liabilities | $3.8M | 76.9% |